Levetiracetam Desitin

Levetiracetam, the active ingredient in Levetiracetam Desitin, is an anticonvulsant presented as an intravenous solution for intravenous use. It is used to control partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Desitin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that modulates neuronal excitability in various seizure types. - Partial‑onset seizures: reduces seizure frequency in patients with focal epilepsy. - Generalized tonic‑clonic seizures: helps achieve seizure control in patients with primary generalized epilepsy. - Myoclonic seizures: diminishes myoclonic jerks and improves overall seizure management.

Levetiracetam may cause a range of adverse reactions.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or weak. - Somnolence: increased sleepiness during the day. - Headache: mild to moderate cranial pain. - Irritability: mood changes or increased agitation. - Nausea: upset stomach or feeling of queasiness.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: serious skin disorder with blistering. - Blood dyscrasias: abnormal blood counts such as neutropenia. - Suicidal thoughts or behavior: emergence of depressive symptoms. - Severe depression: marked mood disturbances requiring medical attention.

Levetiracetam requires careful monitoring in specific clinical situations. - Renal impairment: monitor renal function and consider dose adjustment. - Hepatic impairment: use with caution and observe for altered metabolism. - Pregnancy: risk unknown; weigh benefits against potential fetal exposure. - Concomitant CNS depressants: monitor for additive sedation or respiratory depression. - Psychiatric symptoms: observe for mood changes, aggression, or suicidal ideation. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Levetiracetam has a relatively low interaction profile, but certain agents can affect its plasma levels.

Major Interactions (Avoid): - Strong enzyme inducers (e.g., carbamazepine, phenytoin, phenobarbital): may significantly lower levetiracetam concentrations, reducing efficacy. - Live vaccines: concurrent use may increase risk of vaccine‑related adverse events.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance central nervous system depression and increase somnolence. - Other antiepileptic drugs (e.g., valproate): may require therapeutic drug monitoring. - Sedating antihistamines or opioids: monitor for additive sedation and respiratory effects.